PTEN reduction and loss have also been reported in human cancers [5,6,13,58] and in canine melanoma [16], hemangiosarcoma [17], osteosarcoma [18], and in CMTs and FMTs [2,22]. The gene discussed is PTEN; the disease is cancer.